Physician profile
Dennis J Pfisterer
NPI 1669795498
$36,685.14
in general payments reported to CMS, 2019-2025
11 companies · $9,402 in 2025
The $9,402 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $554 · 2021: $907 · 2022: $3,434 · 2023: $2,660 · 2024: $20K · 2025: $9,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $6,218 · Travel and Lodging: $5,170 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Education: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,637.50 |
| Food and Beverage | $6,217.71 |
| Travel and Lodging | $5,169.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Education | $264.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $28,340.22 | 2022-2025 | Excelsiusgps Robotic Navigation System, Globus Trauma, Onvoy |
| Zimmer Biomet Holdings, INC. | $3,526.68 | 2021-2025 | Avenir, Comprehensive Shoulder System, Persona |
| Arthrex, INC. | $1,547.68 | 2022 | |
| Seapearl East, INC | $1,181.69 | 2021-2025 | |
| Depuy Synthes Sales INC. | $751.85 | 2020-2022 | |
| Kerecis Limited | $677.37 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Royal Biologics, INC. | $347.03 | 2020-2021 | |
| Smith+Nephew, INC. | $137.54 | 2025 | Legion Revision |
| Stryker Corporation | $124.99 | 2022 | |
| Bonalive INC | $35.34 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $14.75 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Pfisterer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.